The Art of Innovation: How to Become a “Partner of Choice” is an insightful interview with seasoned innovation professionals discussing what it takes to build a Partner-of Choice-relationship with Open Innovation in the pharmaceutical industry.
Author: Stephan Klaschka
Stephan Klaschka is an awarded innovation executive and management consultant, serial entrepreneur and intrapreneur, and a public speaker with over 25 years of international work experience in life-sciences and other industries. He held a number of senior business operations, strategy and innovation roles with Boehringer Ingelheim (bio-tech and pharmaceuticals), leaving as Director of Global Innovation Management and Strategy. In this capacity, Mr. Klaschka reported into the Chief Information Officer (CIO) as catalyst to drive pivotal innovations and disruptive transformation across all companies and businesses worldwide. He established and implemented global innovation strategy with focus on Digital, Social, Growth and Sustainability including new business models and growth opportunities, health aging and independent living, emerging technologies, collaborations, networks. Previously, he was Director, Head of Clinical Applications Support and Compliance Officer in charge of the Europe/Africa and then North/South America regions. Mr. Klaschka has recently served as CEO interim of the German Institute for Telemedicine and Health Promotion (DITG GmbH), which specializes in holistic and sustainable telemedical care provision for chronic diseases in prevention and treatment. He holds Masters Degrees in Computer Science and Management, an Executive MBA as well as advanced degrees in Strategy, Innovation, and Leadership from leading schools in Europe and the Unites States in addition to the Project Management Professional (PMP) certification. Mr. Klaschka has published extensively and created top-ranking, practical workshops on topics including exponential innovation in healthcare, intrapreneurship, innovative workplaces, and new technologies in healthcare and life sciences, primarily. He consults independently also in digital innovation and AI-based analytics as Founder of Stephan Klaschka Consulting LLC, New York. View all posts by Stephan Klaschka